132 filings
Page 5 of 7
8-K
zgnyn7z5wk
5 Jan 18
Departure of Directors or Certain Officers
12:00am
8-K
ngq6p9nk9o dfh0yvj
8 Nov 17
Ophthotech Reports Third Quarter 2017 Financial and Operating Results
12:00am
8-K
azyyurn xp515c6c
7 Nov 17
Entry into a Material Definitive Agreement
12:00am
8-K
xe1lpcdo4tg0
27 Oct 17
Termination of a Material Definitive Agreement
12:00am
8-K
8nlp43ozs0tep7j1p
14 Aug 17
Ophthotech Announces Results from Third Phase 3 Trial of Fovista® in Wet Age-Related Macular Degeneration
12:00am
8-K
634vng40
26 Jul 17
Results of Operations and Financial Condition
12:00am
8-K
dd944cver6i8dran5a7z
10 Jul 17
Entry into a Material Definitive Agreement
12:00am
8-K
mtr2hqiu
22 May 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
1lsvmhfsaf5k
3 May 17
Ophthotech Reports First Quarter 2017 Financial and Operating Results
12:00am
8-K
mrmtt 1t2o4yult0
24 Apr 17
Departure of Directors or Certain Officers
12:00am
8-K
27nzmwawbpy
28 Feb 17
Ophthotech Reports Fourth Quarter and Full Year 2016 Financial and Operating Results
12:00am
8-K
1tc3as1430tb8abx6vyo
24 Feb 17
Departure of Directors or Certain Officers
12:00am
8-K
l6ei3
1 Feb 17
Termination of a Material Definitive Agreement
12:00am
8-K
jwhlz7x1
17 Jan 17
Departure of Directors or Certain Officers
12:00am
8-K
4wpn7v0 plqz4ye
6 Jan 17
Termination of a Material Definitive Agreement
12:00am
8-K
unpsa
16 Dec 16
Cost Associated with Exit or Disposal Activities
12:00am
8-K
b6avc2joxoewjxqikcc
12 Dec 16
Other Events
12:00am
8-K
suqrlzhn8ooj fz
8 Nov 16
Ophthotech Reports Third Quarter 2016 Financial and Operating Results
12:00am
8-K
az3qmy7e
4 Nov 16
Entry into a Material Definitive Agreement
12:00am
8-K
8d6clqb
3 Aug 16
Ophthotech Reports Second Quarter 2016 Financial and Operating Results
12:00am